83 related articles for article (PubMed ID: 10362262)
1. The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases.
Broome MA; Galisteo ML; Schlessinger J; Courtneidge SA
Oncogene; 1999 May; 18(18):2908-12. PubMed ID: 10362262
[TBL] [Abstract][Full Text] [Related]
2. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
3. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
4. c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts.
Odai H; Sasaki K; Hanazono Y; Ueno H; Tanaka T; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Jpn J Cancer Res; 1995 Dec; 86(12):1119-26. PubMed ID: 8635998
[TBL] [Abstract][Full Text] [Related]
5. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain.
Miyake S; Mullane-Robinson KP; Lill NL; Douillard P; Band H
J Biol Chem; 1999 Jun; 274(23):16619-28. PubMed ID: 10347229
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.
Galisteo ML; Dikic I; Batzer AG; Langdon WY; Schlessinger J
J Biol Chem; 1995 Sep; 270(35):20242-5. PubMed ID: 7657591
[TBL] [Abstract][Full Text] [Related]
7. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
[TBL] [Abstract][Full Text] [Related]
8. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
Thien CB; Langdon WY
Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
[TBL] [Abstract][Full Text] [Related]
9. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
[TBL] [Abstract][Full Text] [Related]
10. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
Broome MA; Hunter T
J Biol Chem; 1996 Jul; 271(28):16798-806. PubMed ID: 8663329
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
Thien CB; Langdon WY
Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
[TBL] [Abstract][Full Text] [Related]
12. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
[TBL] [Abstract][Full Text] [Related]
13. cbl-b inhibits epidermal growth factor receptor signaling.
Ettenberg SA; Keane MM; Nau MM; Frankel M; Wang LM; Pierce JH; Lipkowitz S
Oncogene; 1999 Mar; 18(10):1855-66. PubMed ID: 10086340
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
Bisson SA; Ujack EE; Robbins SM
Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836
[TBL] [Abstract][Full Text] [Related]
15. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases.
Szymkiewicz I; Kowanetz K; Soubeyran P; Dinarina A; Lipkowitz S; Dikic I
J Biol Chem; 2002 Oct; 277(42):39666-72. PubMed ID: 12177062
[TBL] [Abstract][Full Text] [Related]
16. The Src-like adaptor protein regulates PDGF-induced actin dorsal ruffles in a c-Cbl-dependent manner.
Sirvent A; Leroy C; Boureux A; Simon V; Roche S
Oncogene; 2008 May; 27(24):3494-500. PubMed ID: 18193084
[TBL] [Abstract][Full Text] [Related]
17. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.
Blake RA; Broome MA; Liu X; Wu J; Gishizky M; Sun L; Courtneidge SA
Mol Cell Biol; 2000 Dec; 20(23):9018-27. PubMed ID: 11074000
[TBL] [Abstract][Full Text] [Related]
18. Evidence for functional roles of Crk-II in insulin and epidermal growth factor signaling in Rat-1 fibroblasts overexpressing insulin receptors.
Ishiki M; Sasaoka T; Ishihara H; Imamura T; Usui I; Takata Y; Kobayashi M
Endocrinology; 1997 Nov; 138(11):4950-8. PubMed ID: 9348226
[TBL] [Abstract][Full Text] [Related]
19. Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling.
Ueno H; Sasaki K; Miyagawa K; Honda H; Mitani K; Yazaki Y; Hirai H
J Biol Chem; 1997 Mar; 272(13):8739-43. PubMed ID: 9079708
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
